Evidence map›Paper›PMID 32535494›Full record

ArticleStem cell research2020

Differential regulation of lineage commitment in human and mouse primed pluripotent stem cells by the nucleosome remodelling and deacetylation complex.

Ramy Ragheb, Sarah Gharbi, Julie Cramard, Oluwaseun Ogundele, Susan L Kloet, Thomas Burgold, Michiel Vermeulen, Nicola Reynolds, Brian Hendrich

Open access · goldAbstract read
In one paragraph

Article in Stem cell research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Ramy RaghebWellcome - MRC Stem Cell Institute, University of Cambridge, Cambridge CB2 0AW, United Kingdom.
Sarah GharbiWellcome - MRC Stem Cell Institute, University of Cambridge, Cambridge CB2 0AW, United Kingdom.
Julie CramardWellcome - MRC Stem Cell Institute, University of Cambridge, Cambridge CB2 0AW, United Kingdom.
Oluwaseun OgundeleWellcome - MRC Stem Cell Institute, University of Cambridge, Cambridge CB2 0AW, United Kingdom.
Susan L KloetDepartment of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University, 6525 GA Nijmegen, The Netherlands.
Thomas BurgoldWellcome - MRC Stem Cell Institute, University of Cambridge, Cambridge CB2 0AW, United Kingdom.
Michiel VermeulenDepartment of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University, 6525 GA Nijmegen, The Netherlands; Oncode Institute, Radboud University, 6525 GA Nijmegen, The Netherlands.
Nicola ReynoldsWellcome - MRC Stem Cell Institute, University of Cambridge, Cambridge CB2 0AW, United Kingdom.
Brian HendrichWellcome - MRC Stem Cell Institute, University of Cambridge, Cambridge CB2 0AW, United Kingdom; Department of Biochemistry, University of Cambridge, Cambridge CB2 1QR, United Kingdom. Electronic address: bdh24@cam.ac.uk.
University of Cambridge · GBRadboud University Medical Center · NLWellcome/MRC Cambridge Stem Cell Institute · GB

Funding

Medical Research Council MC_PC_12009Medical Research Council MC_PC_17230Medical Research Council MR/R009759/1Wellcome Trust 203151/Z/16/ZWellcome Trust 206291/Z/17/Z
6 · The paper itself

Abstract

Differentiation of mammalian pluripotent cells involves large-scale changes in transcription and, among the molecules that orchestrate these changes, chromatin remodellers are essential to initiate, establish and maintain a new gene regulatory network. The Nucleosome Remodelling and Deacetylation (NuRD) complex is a highly conserved chromatin remodeller which fine-tunes gene expression in embryonic stem cells. While the function of NuRD in mouse pluripotent cells has been well defined, no study yet has defined NuRD function in human pluripotent cells. Here we find that while NuRD activity is required for lineage commitment from primed pluripotency in both human and mouse cells, the nature of this requirement is surprisingly different. While mouse embryonic stem cells (mESC) and epiblast stem cells (mEpiSC) require NuRD to maintain an appropriate differentiation trajectory as judged by gene expression profiling, human induced pluripotent stem cells (hiPSC) lacking NuRD fail to even initiate these trajectories. Further, while NuRD activity is dispensable for self-renewal of mESCs and mEpiSCs, hiPSCs require NuRD to maintain a stable self-renewing state. These studies reveal that failure to properly fine-tune gene expression and/or to reduce transcriptional noise through the action of a highly conserved chromatin remodeller can have different consequences in human and mouse pluripotent stem cells.

Indexed as

Induced Pluripotent Stem CellsPluripotent Stem CellsAnimalsCell DifferentiationDNA-Binding ProteinsHumansMi-2 Nucleosome Remodeling and Deacetylase ComplexMiceNucleosomesDNA-Binding ProteinsMi-2 Nucleosome Remodeling and Deacetylase ComplexNucleosomesChromatinepiStem celliPS cellLineage commitmentPluripotencyTranscriptomics

Identifiers

PMID32535494
PMCPMC7347010
OpenAlexW3033195847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.